Kiora Pharma appoints Keith J. Lane EVP of global clinical development, regulatory affairs - KPRX News | RalliesKiora Pharma appoints Keith J. Lane EVP of global clinical development, regulatory affairs
K
KPRX• Kiora Pharma appoints new EVP of global clinical development and regulatory affairs
- Kiora Pharmaceuticals appointed Keith J. Lane as executive vice president of global clinical development and regulatory affairs.
- Lane previously served as chief scientific officer at Ora, overseeing clinical operations and regulatory strategy for more than 60 ophthalmic trials.
- His background includes more than 20 years in ophthalmic drug development across Phase 1 to Phase 4 programs.
•
